BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,264,091 | +124.6% | 158,911 | +123.1% | 0.05% | +138.1% |
| Q2 2023 | $7,687,314 | -13.7% | 71,225 | -0.4% | 0.02% | -22.2% |
| Q1 2023 | $8,905,385 | -17.1% | 71,489 | 0.0% | 0.03% | -25.0% |
| Q4 2022 | $10,739,078 | -13.5% | 71,489 | -22.4% | 0.04% | -10.0% |
| Q3 2022 | $12,422,000 | +10.9% | 92,095 | +22.6% | 0.04% | +11.1% |
| Q2 2022 | $11,200,000 | -2.9% | 75,118 | +11.1% | 0.04% | +28.6% |
| Q1 2022 | $11,534,000 | -42.7% | 67,622 | -13.5% | 0.03% | -34.9% |
| Q4 2021 | $20,145,000 | -62.9% | 78,142 | -60.7% | 0.04% | -65.0% |
| Q3 2021 | $54,272,000 | -25.1% | 198,804 | -38.6% | 0.12% | -25.9% |
| Q2 2021 | $72,487,000 | +162.4% | 323,777 | +28.0% | 0.17% | +144.1% |
| Q1 2021 | $27,623,000 | +132.1% | 252,977 | +73.3% | 0.07% | +134.5% |
| Q4 2020 | $11,899,000 | – | 145,963 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |